Clinical Trials
12
3 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
N/A
Active, not recruiting
3
25.0%
Completed
4
33.3%
Withdrawn
5
41.7%
No approval data available
- ProofPilot has acquired Lokavant, a clinical trial intelligence company spun out of Roivant in 2020, to integrate advanced predictive analytics into clinical trial execution. - The combined platform leverages AI-powered forecasting to help sponsors and CROs reduce non-conformance events by 70% and improve forecasting accuracy by 70x. - Lokavant's Spectrum solution delivers real-time forecasts with over 80% confidence, enabling clinical teams to anticipate challenges and optimize study performance. - The acquisition creates an end-to-end platform that combines digital trial planning, execution, and predictive intelligence to accelerate therapy delivery to patients.
- ProofPilot and the Digital Medicine Society (DiMe) have formed a strategic partnership to develop innovative digital tools for clinical research, with an initial focus on preventing opioid use disorder relapse. - The collaboration will leverage ProofPilot's Clinical Experience Platform to enhance study experiences, simplify data collection, and provide streamlined digital solutions for clinical trial participants and sites. - The partnership aims to define and collect physiological signals, behavior traits, and mental health characteristics to train a digital tool specifically designed to prevent OUD relapse and reduce related deaths.
- ProofPilot, a Clinical Experience Platform, has partnered with Inspire, an online health community platform with over 10 million annual visitors across 3,000 disease states, to expand patient recruitment for clinical trials. - The collaboration aims to connect Inspire's diverse patient community with appropriate clinical trials through ProofPilot's Patient Recruitment Network, creating a streamlined digital experience for trial participation. - This partnership addresses a critical industry challenge by removing barriers to clinical trial participation while enabling both companies to focus on their core strengths in patient engagement and clinical trial management.
